DESCRIPTION (provided by applicant): The goal of this research is to determine how both the dynamics and spatial organization of the actin and microtubule cytoskeletons are coordinated by a group of five interacting mammalian proteins: APC, Dia1, EB1, CLIP-170, and capping protein. This work will define the functions and mechanisms of these proteins in microtubule-actin cross-regulation, and will thereby provide a deeper understanding of the molecular activities and interactions that underlie such processes as cell migration, cell adhesion, and cell and tissue morphogenesis. This project uses bulk biochemical experiments combined with novel multi-wavelength single molecule fluorescence methods that we have tailored to directly observe the mechanisms of complex multi- component regulatory systems in vitro. Further, the mechanisms deduced from the experiments in vitro will be tested in vivo to confirm that they are important for specific cellular functions of these proteins. The Specific Aims are: (1) Test the hypothesis that the microtubule plus end-binding protein EB1 directly regulates nucleation of actin filaments by APC-Dia1; (2) Test the hypothesis that the rate and duration of actin filament elongation is controlled by dynamic binding interactions of Dia1, capping protein, microtubules, and/or EB1 at barbed ends; and (3) Define the roles of APC, Dia1, EB1, and CLIP-170 in controlling microtubule plus end dynamics and in triggering ultrafast actin polymerization from microtubule plus ends.
Public Health Relevance Statement
PUBLIC HEALTH RELEVANCE: This grant is an investigation of the organization and regulation of actin and microtubule cytoskeletons by the combined effects of five proteins: APC, Capping protein, Dia1, EB1, and CLIP-170. APC (Adenomatous polyposis coli) is a tumor suppressor. Mutation of the human Apc gene is an early step in the progression of over 80% of colorectal cancers, inherited and sporadic. Interactions with disease-associated proteins have implicated Kinesin-1 in Alzheimer's, Huntington's, and Parkinson's diseases. Further, fusion of the EB1 and MLL genes can lead to acute lymphoblastic leukemia. For these reasons, this research may provide new insights into the underlying mechanisms of tumorigenesis. In addition, the work is designed to uncover basic mechanisms of cellular biochemistry that will contribute to understanding disease states in as-yet-unanticipated ways.
No Sub Projects information available for 5R01GM098143-06
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01GM098143-06
Patents
No Patents information available for 5R01GM098143-06
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01GM098143-06
Clinical Studies
No Clinical Studies information available for 5R01GM098143-06
News and More
Related News Releases
No news release information available for 5R01GM098143-06
History
No Historical information available for 5R01GM098143-06
Similar Projects
No Similar Projects information available for 5R01GM098143-06